📰 Markw Hahn News
Markw Hahn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Markw Hahn. Real-time updates on events, politics, business and more.
October 10, 2023
Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s stock price dropped 3% on Tuesday . The company traded as low as $14.45 and last traded at $14.47. Approximately 9,857 shares changed hands during trading, a decline of 98% from the average daily volume of 457,852 shares. The stock had previously closed at $14.92. Analysts Set […]
October 10, 2023
Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s stock price was down 3% during mid-day trading on Tuesday . The stock traded as low as $14.45 and last traded at $14.47. Approximately 9,857 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 457,852 shares. The stock had previously […]
August 23, 2023
Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) rose 4.6% during trading on Monday . The stock traded as high as $19.06 and last traded at $19.04. Approximately 88,910 shares changed hands during trading, a decline of 82% from the average daily volume of 500,320 shares. The stock had previously closed at $18.20. […]
May 13, 2023
Verona Pharma plc (NASDAQ:VRNA – Get Rating) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 2,290,000 shares, a growth of 21.8% from the April 15th total of 1,880,000 shares. Based on an average daily volume of 558,400 shares, the short-interest ratio is […]
May 2, 2023
Verona Pharma (NASDAQ:VRNA – Get Rating) is scheduled to be releasing its earnings data before the market opens on Tuesday, May 9th. Analysts expect Verona Pharma to post earnings of ($0.22) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link. Verona Pharma (NASDAQ:VRNA […]
May 1, 2023
Verona Pharma plc (NASDAQ:VRNA – Get Rating) has received a consensus rating of “Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12 month target price among brokerages that have issued ratings on the stock in the […]
January 7, 2022
06.01.2022 - ALSP Orchid Acquisition Corporation I (Nasdaq: ALORU) (the “Company” or “ALSP Orchid”) announced today that, commencing January 10, 2022, holders of the units sold in the Company’s initial public offering of 172,500,000 units, completed on November ...